
|Articles|November 1, 2012
Dermatology Times, Digital Edition, November 2012
The Casualties of Cutting : Both government & private-payer reimbursements continue to decline. Will the care that dermatologists provide suffer? All about Apps Clinical Dermatology : Practical dosing tips provide strategies for optimizing psoriasis control with biologics Cosmetic Dermatology : ‘Sensitive skin’ remains a marketing term with no medical definition Cutaneous Oncology : New topical, systemic therapies may improve survival of patients with CTCL Practice Management : Don’t hurry through the EHR selection and purchasing process
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
AbbVie Files for Vitiligo Indication, Putting Systemic Therapy Under Regulatory Review
2
UCB Presents 3-Year BE HEARD Trial Results for Bimekizumab in Moderate-to-Severe HS
3
Kicking Off MOPD 2026 With Lawrence Schachner, MD
4
Sagimet and Ascletis Report Positive 52-Week Safety and Efficacy Data for Denifanstat in Acne
5











